We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Brain Health After COVID-19, Pneumonia, Myocardial Infarction, or Critical Illness.
- Authors
Peinkhofer, Costanza; Zarifkar, Pardis; Christensen, Rune Haubo B.; Nersesjan, Vardan; Fonsmark, Lise; Merie, Charlotte; Lebech, Anne-Mette; Katzenstein, Terese Lea; Bang, Lia Evi; Kjærgaard, Jesper; Sivapalan, Pradeesh; Jensen, Jens-Ulrik Stæhr; Benros, Michael Eriksen; Kondziella, Daniel
- Abstract
Key Points: Question: Do patients hospitalized for COVID-19 have long-term cognitive, psychiatric, or neurological complications compared with healthy controls and matched patients hospitalized for non–COVID-19 medical conditions of similar severity? Findings: In this matched cohort study including 345 participants, patients hospitalized for COVID-19 performed worse than healthy controls on cognitive, psychiatric, and neurological tests. However, compared with hospitalized controls matched for age, sex, and severity of disease, the impairment of brain health was similar. Meaning: This study suggests that the brain health of patients was impaired after severe COVID-19, but no more than the brain health of patients hospitalized for other diseases of similar severity. Importance: Brain health is most likely compromised after hospitalization for COVID-19; however, long-term prospective investigations with matched control cohorts and face-to-face assessments are lacking. Objective: To assess whether long-term cognitive, psychiatric, or neurological complications among patients hospitalized for COVID-19 differ from those among patients hospitalized for other medical conditions of similar severity and from healthy controls. Design, Setting, and Participants: This prospective cohort study with matched controls was conducted at 2 academic hospitals in Copenhagen, Denmark. The case cohort comprised patients with COVID-19 hospitalized between March 1, 2020, and March 31, 2021. Control cohorts consisted of patients hospitalized for pneumonia, myocardial infarction, or non–COVID-19 intensive care–requiring illness between March 1, 2020, and June 30, 2021, and healthy age- and sex-matched individuals. The follow-up period was 18 months; participants were evaluated between November 1, 2021, and February 28, 2023. Exposures: Hospitalization for COVID-19. Main Outcomes and Measures: The primary outcome was overall cognition, assessed by the Screen for Cognitive Impairment in Psychiatry (SCIP) and the Montreal Cognitive Assessment (MoCA). Secondary outcomes were executive function, anxiety, depressive symptoms, and neurological deficits. Results: The study included 345 participants, including 120 patients with COVID-19 (mean [SD] age, 60.8 [14.4] years; 70 men [58.3%]), 125 hospitalized controls (mean [SD] age, 66.0 [12.0] years; 73 men [58.4%]), and 100 healthy controls (mean [SD] age, 62.9 [15.3] years; 46 men [46.0%]). Patients with COVID-19 had worse cognitive status than healthy controls (estimated mean SCIP score, 59.0 [95% CI, 56.9-61.2] vs 68.8 [95% CI, 66.2-71.5]; estimated mean MoCA score, 26.5 [95% CI, 26.0-27.0] vs 28.2 [95% CI, 27.8-28.6]), but not hospitalized controls (mean SCIP score, 61.6 [95% CI, 59.1-64.1]; mean MoCA score, 27.2 [95% CI, 26.8-27.7]). Patients with COVID-19 also performed worse than healthy controls during all other psychiatric and neurological assessments. However, except for executive dysfunction (Trail Making Test Part B; relative mean difference, 1.15 [95% CI, 1.01-1.31]), the brain health of patients with COVID-19 was not more impaired than among hospitalized control patients. These results remained consistent across various sensitivity analyses. Conclusions and Relevance: This prospective cohort study suggests that post–COVID-19 brain health was impaired but, overall, no more than the brain health of patients from 3 non–COVID-19 cohorts of comparable disease severity. Long-term associations with brain health might not be specific to COVID-19 but associated with overall illness severity and hospitalization. This information is important for putting understandable concerns about brain health after COVID-19 into perspective. This matched cohort study assesses whether long-term cognitive, psychiatric, or neurological complications among patients hospitalized for COVID-19 differ from those among patients hospitalized for other medical conditions of similar severity and from healthy controls.
- Subjects
MYOCARDIAL infarction risk factors; RISK factors of pneumonia; COVID-19; CONFIDENCE intervals; HEALTH status indicators; CATASTROPHIC illness; RISK assessment; PSYCHOLOGICAL tests; SEVERITY of illness index; RESEARCH funding; DESCRIPTIVE statistics; QUESTIONNAIRES; COGNITIVE testing; LONGITUDINAL method; EVALUATION
- Publication
JAMA Network Open, 2023, Vol 6, Issue 12, pe2349659
- ISSN
2574-3805
- Publication type
Article
- DOI
10.1001/jamanetworkopen.2023.49659